The condition-relevant audience you want to reach today isn't the approved third-party segment you bought last quarter. Consumers can become patients and a part of your target audience at a moment’s notice based on a symptom that escalates, a new diagnosis, an HCP recommendation, or a caregiver's nudge. In fact, a McKinsey Health Consumer Survey found that 70% of consumers act within 48 hours of researching symptoms or treatment.
That means if your third-party segments and your campaign aren't moving at the same speed as the evolving patient population, you're already behind. Now multiply that volatility against the roughly 227 million U.S. adults who see a doctor every year. Add to that the roughly 1,650 heart attacks, 2,630 new heart-failure diagnoses, and 2,180 strokes that happen every day in the U.S. The windows you're trying to hit are narrow, constantly shifting, and a list built last quarter can't see any of them.
Keeping pace isn't just about buying differentiated segments, though. What determines whether any audience actually performs is the demand-side platform (DSP) running it. A third-party audience tells a DSP who to reach based on relevance, but the DSP decides how to bid on every impression.
A generalist DSP bids on that audience as though every impression inside it is equally valuable, even when it isn't. If neither the audience nor the platform running it can tell you who's ready to act right now, volume becomes the only lever left to pull. A health-specialized DSP gives that same audience its best chance to reach and engage the people who are actually relevant, because it acts on real-time clinical and digital signals and knows which cohorts inside that audience matter most today. That means budgets follow relevance instead of chance, and spend gets optimized clinically instead of randomly.
Choosing to work with a health-specialized DSP puts you ahead of a market optimizing for scale, but that decision doesn't end the work to improve clinical impact. Not every health DSP is built the same way, and the gap between them can matter just as much as the gap between generalist and specialist platforms does.
So how do you know which DSP is right for your DTC health marketing campaigns? It starts with understanding what Audience Quality (AQ) — the industry's performance benchmark — actually measures, where it falls short, and what it takes to outperform the rest.
How Audience Quality Became the Generalist DSP Performance Benchmark and Why Health Marketers Need More
Audience quality (AQ) became the industry's default proxy for relevance, and the industry’s way to judge from the outside whether a third-party audience — and the platform running it — is actually working. Therefore, generalist DSPs optimized for scale and CPM and third-party audiences have traditionally been built to score well against that metric. The issue for Health Marketers though is that AQ tells you an audience fits a target profile, but it doesn't tell you the people within it are all ready to act now. In DTC healthcare marketing, that gap is where budgets quietly disappear.
Because audience scoring happens once and is rarely revisited until that same audience is activated again, the model can't account for how much the population shifts in between. An estimated 55% of digital healthcare ad spend is wasted on low-quality audiences — the direct cost of chasing volume at the expense of clinical or real-time relevance.
Generalist DSPs can help a campaign hit its AQ target and impression goals — and still miss, because they bid the same on someone who merely fits the profile as they do on someone who's actually in-market right now. And a targeting miss in healthcare isn't only a performance problem. When accuracy affects patient safety, brand trust, and regulatory exposure, a "cheap" solution can carry hidden costs no CPM comparison will ever show you.
That's the real difference between optimizing for AQ versus qualified patients. The question worth asking isn't "how do we score higher on AQ" — it's "how do we know this audience still reflects who's actually in-market today." Once you're asking that question, you're no longer comparing cost per impression; you're comparing cost per qualified patient, and the next question is what's actually driving that qualification.
Don’t Choose Between Your Third-Party Data and Real-Time Precision
None of this is an argument for abandoning the third-party audiences you've already invested in. It's an argument for flexibility. The right DSP doesn't just optimize third-party segments when you need broad category reach or a starting point for patient populations you haven't yet identified like a generalist DSP might do at best. The right DSP also provides real-time targeting and segmentation opportunities that give you the best chance of reaching everyone relevant to your brand right now.
PulsePoint's platform gives you control to do it all, in one connected environment, without stitching together vendors who each solve one piece of the problem and leave you to manage the rest. Our responsive data foundation and platform can ingest and act on signals that move as fast as the patients health marketers are trying to reach.
We enable you to run third-party audiences effectively, layer on additional targeting attributes, and build Lookalike Audiences — all within one platform. When relevance and receptivity, not just reach, are what decide whether a campaign performs, you can also build real-time, clinically focused Bespoke Audiences directly within DTC Explorer: PulsePoint's self-service audience curation workspace, and the reason you no longer have to choose between the reach of third-party data and the precision of real-time signals for optimal outcomes.
How to Build and Activate a DTC Bespoke Audience in 24 Hours
Speed is the advantage that changes everything. DTC Explorer enables users to publish a fully modeled, activation-ready Bespoke Audience in as little as 24 hours — a turnaround no other solution in DTC pharma marketing offers today. Building a clinically relevant audience anywhere else means a multi-week manual process and several handoffs between vendors. DTC Explorer replaces that cycle with a self-service workspace built directly on PulsePoint's data foundation.
You choose where to start: an NPI list anchored to your own HCP campaigns, a prescriber profession or specialty, or any combination of patient attributes and clinical behaviors. From there, you layer in a lookback window anywhere from one month to a full year and tune the balance between precision and reach until the mix reflects exactly who you're trying to find. Once you finalize that seed data, PulsePoint's audience modeling turns it into a Bespoke Audience — ready to activate in as little as 24 hours.
If you start a Bespoke Audience from an NPI SmartList™ within DTC Explorer, your DTC targeting evolves automatically as prescribers enter or exit your target set, built on the de-identified patient attributes most commonly shared among people under the care of those prescribers. It's an audience that keeps evolving — as clinical behavior shifts, as your prescriber set changes, as the population most likely to act today changes shape. That's the real advantage of DTC Explorer: not just that you can build a Bespoke Audience yourself, but that you can do it, and keep doing it. It's the difference between reaching a patient while they're still deciding, and reaching them after the decision was made.
Built on Health Audience Data and Technology You Can Trust
That speed is only possible because of what's running underneath it: high-quality data, technology that acts on real-time signals with a privacy-forward approach, all within one connected ecosystem.
Every Bespoke Audience is built from de-identified claims data, modeled entirely within a clean room environment. Our architecture makes Personally Identifiable Information (PII) inaccessible by design, so you can move at the speed the market demands without trading away compliance to get there.
That architecture rests on three data assets working together. An identity graph connects signals across devices and touchpoints, so consumer activity resolves to a consistent record rather than a handful of disconnected fragments. Unique clinical data assets — de-identified medical and pharmacy claims — supply the diagnosis, treatment, and prescribing detail that makes an audience clinically meaningful in the first place. And integrations with Medscape and WebMD add a layer of real-world health engagement, capturing when and how consumers are actually researching symptoms, conditions, and treatments. Together, those three pieces are the high-quality data the rest of DTC Explorer runs on, with these use cases certified under a HIPAA expert determination to ensure the data remains de-identified.
On top of that foundation, we understand where consumer populations with specific conditions are concentrated, down to the ZIP code, refreshed continuously as clinical behaviors evolve. The same foundation that powers context, prevalence, and location signals across 230 million de-identified patients and billions of medical and pharmacy claims is what DTC Explorer seed data draws on.
Layered on top of that, engagement signals — recency, frequency, and depth — surface the high-value cohorts already showing intent: condition-relevant consumers reading clinically relevant content, or with a likely connection to brand-relevant HCPs. As new consumers are diagnosed or start treatment, that combination keeps you reaching the most relevant audience in the moment, no matter when your campaign happens to be running, and lets you act first — while a static segment is still finding out these patients exist.
Audience Quality Was Never the Finish Line for DTC Pharma Marketing
The marketers who win in DTC health advertising are the ones who ask a harder question of their data — not just "does this person qualify," but "are they ready, right now" — and who have a platform with the data and technology equipped to answer it.
PulsePoint is one platform with full interoperability across analytics, segmentation, planning, activation, and measurement, so the same real-time signals that build your Bespoke Audience also inform how it's optimized and where it's activated.
That's what makes omnichannel actually attainable: signals that inform and optimize outcomes at the same time, orchestrating your entire media strategy instead of just one piece of it.
Ready to build DTC Explorer Bespoke Audience segments now? Request a demo today.
.jpeg)
